BORDONARO, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 97
NA - Nord America 62
EU - Europa 32
SA - Sud America 4
AF - Africa 2
Totale 197
Nazione #
US - Stati Uniti d'America 59
SG - Singapore 38
CN - Cina 27
IT - Italia 17
HK - Hong Kong 10
VN - Vietnam 10
AT - Austria 5
DE - Germania 5
ID - Indonesia 5
FR - Francia 4
BR - Brasile 3
IN - India 3
CA - Canada 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AR - Argentina 1
FI - Finlandia 1
IQ - Iraq 1
KE - Kenya 1
MN - Mongolia 1
NI - Nicaragua 1
TR - Turchia 1
Totale 197
Città #
San Jose 18
Ashburn 11
Hong Kong 10
Singapore 9
Ho Chi Minh City 4
Turin 4
Vienna 4
Beijing 3
Bologna 2
Hanoi 2
Hillsboro 2
Messina 2
Milan 2
Ajman 1
Bandung 1
Banyuwangi 1
Bientina 1
Chandigarh 1
Chennai 1
Chicago 1
Denpasar 1
Frankfurt am Main 1
Garbagnate Milanese 1
Haiphong 1
Helsinki 1
Hải Dương 1
Inajá 1
Jakarta 1
Joinville 1
Lake Worth 1
Luanda 1
Managua 1
Manassas 1
Mersin 1
Montreal 1
New York 1
Orem 1
Piscataway 1
Plano 1
Pune 1
Quảng Ngãi 1
Reston 1
Río Gallegos 1
Santa Clara 1
Surabaya 1
São Paulo 1
Ulan Bator 1
Totale 107
Nome #
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 22
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 21
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 16
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 16
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 15
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 15
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 15
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 13
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 13
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 13
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 12
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 12
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 10
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 10
Tromboembolismo in oncologia medica 10
Totale 213
Categoria #
all - tutte 1.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026213 0 0 0 18 39 52 12 37 23 24 6 2
Totale 213